Sign in

Theranos exposed

2015Contested

Wall Street Journal reporting shows that blood-testing startup Theranos, once valued at $9 billion, ran most tests on conventional machines. Its founder is later convicted of defrauding investors.

The story

On October 15, 2015, the Wall Street Journal reporter John Carreyrou published an investigation showing that Theranos, a Silicon Valley blood-testing startup valued at about $9 billion, was running most of its patient tests on conventional machines made by other companies, not on its own device. Founded in 2003 by Elizabeth Holmes, who dropped out of Stanford at 19, the company promised that a few drops of blood from a finger prick could run hundreds of tests cheaply and quickly. Its board was packed with prominent figures, including George Shultz, Henry Kissinger and James Mattis, but had almost no medical or laboratory expertise.

The reporting, helped by insiders, set off federal inspections that found serious lab problems, and Theranos voided two years of results from its Edison machine. Partners such as Walgreens, which had opened testing sites in its stores, pulled out, and the company dissolved in 2018. Holmes was convicted in January 2022 of four counts of fraud and conspiracy involving investors, and was acquitted of the counts involving patients. She was sentenced to 11 years and 3 months in prison, and her former partner Ramesh Balwani received nearly 13 years. The case became a symbol of the risk of 'fake it till you make it' in start-up culture.

Why it mattered

  • Investors and regulators grew more skeptical of hyped start-ups with no independent verification of their technology.
  • Holmes's conviction showed that start-up founders can face criminal prosecution for misleading investors.
  • The case drew attention to gaps in US oversight of lab-developed tests and led to proposals to tighten it.
  • Carreyrou's book Bad Blood and later films made the story a global lesson in investigative reporting and corporate hype.

Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made

Contested history

Consensus: Theranos's device could run only a limited set of tests and was less reliable than claimed; founder Elizabeth Holmes was convicted in 2022 of defrauding investors.

The founder knowingly misled investorsEstablished
A jury convicted her of conspiracy and three counts of wire fraud involving investors.
She also defrauded patientsDebated
The jury acquitted her on the patient counts, although regulators found the lab's results put patients at risk.
The company was a victim of the press and competitorsUnsupported
Federal lab inspectors found serious deficiencies in 2016, independent of the reporting.
Where this claim comes from, and its rebuttals

Community notes

Loading notes…

Learn more ranked by votes

BookJohn Carreyrou
Bad Blood
Search Open Library
VideoSearch YouTube
Theranos scandal explained
Search YouTube
VideoSearch YouTube
Theranos Elizabeth Holmes documentary
Search YouTube